Sequenom snatches up prenatal testing intellectual property; German team spots new thyroid cancer biomarker;

> Sequenom ($SQNM) paid close to $14.6 million for intellectual property from Isis Innovation involving noninvasive prenatal testing. Story (reg. req.)

> Biocept ($BIOC) is expanding its ovarian cancer diagnostics collaboration with MD Anderson Cancer Center. Release

> GE ($GE) named John Flannery as president and CEO of GE Healthcare; Flannery used to be the SVP of business development at the company. Story

> German scientists have identified a new biomarker that points to a cause of thyroid cancer. Item

> Massachusetts Institute of Technology and Tufts University researchers developed a new assay that generates its own synthetic biomarkers to help spot harmful blood clots in mice. Story

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.